Perfil
Joris Winderickx is the founder of reMYND NV, where he currently serves as the Scientific Advisor since 2012.
He founded the company in 2002.
Dr. Winderickx is also the founder of Royal Flemish Chemical Society.
Dr. Winderickx's former job includes being a Director at ADx NeuroSciences NV.
Additionally, he worked as a Professor at Katholieke Universiteit Leuven.
Dr. Winderickx's education includes a doctorate degree from Katholieke Universiteit Leuven.
Cargos activos de Joris Winderickx
| Empresas | Cargo | Inicio |
|---|---|---|
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services Engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders | Corporate Officer/Principal | 30/05/2012 |
Antiguos cargos conocidos de Joris Winderickx.
| Empresas | Cargo | Fin |
|---|---|---|
Royal Flemish Chemical Society | Fundador | - |
ADx NeuroSciences NV
ADx NeuroSciences NV BiotechnologyHealth Technology Develops diagnostic antibodies for neurodegenerative diseases through research | Director/Miembro de la Junta | - |
Katholieke Universiteit Leuven
Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formación de Joris Winderickx.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Katholieke Universiteit Leuven
Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services Engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders | Commercial Services |
ADx NeuroSciences NV
ADx NeuroSciences NV BiotechnologyHealth Technology Develops diagnostic antibodies for neurodegenerative diseases through research | Health Technology |
Royal Flemish Chemical Society |
- Bolsa de valores
- Insiders
- Joris Winderickx
















